Pharmaceutical & Medication Injury Litigation
Expert opinions on psychotropic adverse effects, prescribing and monitoring standard of care, and neurotoxic exposure, from a physician who prescribes these medications in active practice and analyzes their effects on the brain.
WHAT PHARMACEUTICAL CASES DOES A FORENSIC NEUROPSYCHIATRIST HANDLE?
A forensic neuropsychiatrist handles cases where a medication or neurotoxic exposure is alleged to have injured the brain or behavior: psychotropic adverse effects, prescribing and monitoring standard of care, and drug-induced or chemical neurotoxicity. The evaluating physician both prescribes these agents in practice and analyzes how they alter cognition, movement, and mental state.
Where Medication and Toxic Exposure Injure the Brain
These matters share a common thread: a chemical agent, therapeutic or environmental, is alleged to have altered the brain, and the question is whether it did, to what degree, and whether the prescribing or monitoring met the standard of care. Dr. Lodhi evaluates the medical and pharmacologic record and renders opinions in the following areas.
SSRI and Antidepressant Adverse Effects
Claims involving serotonergic antidepressants, including akathisia, activation, discontinuation syndromes, and disputed behavioral effects, assessed against the documented pharmacology and clinical course.
Antipsychotic Movement Disorders
Tardive dyskinesia and neuroleptic malignant syndrome from antipsychotic exposure, including questions of onset, dose relationship, monitoring adequacy, and whether the movement disorder was recognized and managed in time.
Benzodiazepine and Polypharmacy Impairment
Cognitive impairment, falls, and functional decline attributed to benzodiazepines, sedative-hypnotics, and complex polypharmacy, particularly in older adults where the medication burden itself is the injury.
Lithium Toxicity
Acute and chronic lithium toxicity, including neurologic sequelae, the adequacy of level monitoring and renal surveillance, and the interaction of lithium with other agents and medical conditions.
Serotonin Syndrome
Serotonin syndrome from single agents or drug combinations, addressing recognition, the contribution of interacting prescriptions, and the neurologic and cognitive consequences of a severe episode.
Neurotoxic Exposure
Cognitive and behavioral injury from neurotoxic exposure in occupational and environmental settings, including lead and other heavy metals, organic solvents and volatile organic compounds, and carbon monoxide. Exposure history is correlated with the pattern of cognitive and neurobehavioral deficits and with neuroimaging where available.
Prescribing and Monitoring, From a Prescriber
Standard-of-care opinions in medication cases carry the most weight when they come from a physician who does the work being scrutinized. Dr. Lodhi maintains an active prescribing practice, treating the full range of adult conditions and managing the same medications that give rise to these disputes. He selects agents, weighs interactions, orders and interprets monitoring, and manages adverse effects in his own patients, and his prescribing opinions are grounded in that daily work.
A prescribing and monitoring analysis examines the decisions in context. Was the indication appropriate and the choice of agent reasonable? Were baseline assessments and ongoing monitoring, such as lithium levels, metabolic panels, or examination for abnormal movements, performed at the intervals the standard requires? Were interacting medications identified, informed-consent discussions documented, and adverse effects recognized and acted upon once they appeared? Where a deviation is present, the opinion states it plainly and ties it to the pharmacology; where the care was reasonable even though the outcome was poor, the opinion says that too. The same rigor supports opinions retained by plaintiff and by defense counsel, because the analysis follows the record rather than the referral.
The standard of care is also assessed against the clinical setting rather than in the abstract. What is reasonable for a psychiatrist managing a complex regimen differs from what is expected of a primary-care physician initiating a first antidepressant, and monitoring that is feasible in an outpatient clinic differs from what an inpatient or long-term-care setting can provide. A defensible opinion accounts for these realities, for the information actually available to the prescriber at each decision point, and for the boundary between a judgment that was reasonable given what was known and one that fell below the standard. Hindsight, the knowledge that a bad outcome followed, is held apart from the prospective question of whether the care was appropriate when it was rendered.
Causation Methodology
The central question in a medication injury case is whether the agent caused the claimed harm, and answering it requires more than temporal coincidence. Dr. Lodhi applies a structured causation analysis that an opposing expert can test point by point.
Dose and duration. The analysis begins with whether the exposure was sufficient in amount and length of time to produce the effect claimed, measured against the known pharmacology of the agent and, where available, documented drug levels.
Temporality. A defensible opinion establishes that the exposure preceded the injury and that the interval between them is consistent with the recognized mechanism, neither too immediate nor too delayed to fit the pharmacology.
Dechallenge and rechallenge. Where the record documents improvement after the agent was withdrawn, or recurrence when it was resumed, that natural experiment is powerful evidence, and its presence or absence is weighed explicitly.
Alternative explanations. The analysis systematically considers other causes of the same presentation, including the underlying illness being treated, comorbid medical and psychiatric conditions, other medications, substance use, and effort, so that the opinion rests on exclusion as well as association. Findings are correlated with neuroimaging and neurocognitive data where they exist.
Two features of medication cases make this discipline essential. First, the very symptom said to be a drug injury, whether depression, agitation, cognitive slowing, or a movement disturbance, is often also a feature of the condition the drug was prescribed to treat, so association alone proves little. Second, drug levels, monitoring results, and the precise sequence of dosing changes are frequently the decisive facts, and they live in the pharmacy record and laboratory data rather than in the narrative. The analysis is built to be traced back to specific entries in that record.
Why Neuropsychiatric Training Fits Medication Cases
Medication injury cases are brain-behavior questions: they turn on how a chemical altered cognition, movement, mood, or mental state. A physician fellowship-trained in neuropsychiatry can connect a drug's pharmacology to a specific pattern of neurologic and behavioral findings, distinguish a medication effect from the underlying psychiatric illness it was meant to treat, and separate an organic drug injury from a functional or non-credible presentation.
The alternative is to divide the case among a pharmacologist for the drug, a neurologist for the movement or cognitive findings, and a psychiatrist for the mental state, and the seams between those opinions become the openings an opposing attorney works on cross-examination. Combined with forensic training, neuropsychiatric training allows one physician to carry both the prescribing standard-of-care opinion and the causation opinion in a single analysis that ties the pharmacology to the neurologic and behavioral outcome. For related work, see traumatic brain injury litigation, the neuropsychiatric independent medical examination, and when to retain a forensic neuropsychiatrist.
Frequently Asked Questions
What kinds of pharmaceutical cases does a forensic neuropsychiatrist handle?
Cases involving psychotropic medication adverse effects such as tardive dyskinesia, serotonin syndrome, neuroleptic malignant syndrome, benzodiazepine and polypharmacy cognitive impairment, and prescribing standard-of-care disputes, as well as neurotoxic chemical exposure affecting the brain.
How is causation established in a medication injury case?
By examining dose and duration, the temporal relationship between exposure and symptoms, the known pharmacology of the agent, dechallenge and rechallenge where documented, and the systematic exclusion of alternative explanations, correlated with neuroimaging and neurocognitive findings.
Discuss Your Case
A complimentary screening call determines whether your case fits Dr. Lodhi's expertise. Response within 24 to 48 hours.